These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 17659718)
1. Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a. Schott E; Paul F; Wuerfel JT; Zipp F; Rudolph B; Wiedenmann B; Baumgart DC World J Gastroenterol; 2007 Jul; 13(26):3638-40. PubMed ID: 17659718 [TBL] [Abstract][Full Text] [Related]
2. Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a. Rodrigues S; Magro F; Soares J; Nunes AC; Lopes S; Marques M; Rio E; Macedo G Inflamm Bowel Dis; 2010 Dec; 16(12):2001-3. PubMed ID: 20186933 [No Abstract] [Full Text] [Related]
3. Factors leading patients to discontinue multiple sclerosis therapies. Daugherty KK; Butler JS; Mattingly M; Ryan M J Am Pharm Assoc (2003); 2005; 45(3):371-5. PubMed ID: 15991759 [TBL] [Abstract][Full Text] [Related]
4. [Side-effects of the treatment with disease modifying drugs in patients with multiple sclerosis: an analysis of register data in the Yaroslavl region]. Spirin NN; Kasatkin DS; Stepanov IO; Shipova EG; Baranova NS Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):27-33. PubMed ID: 23096035 [TBL] [Abstract][Full Text] [Related]
5. Rapid onset of ulcerative colitis after treatment with interferon β1a in a patient with multiple sclerosis. Tuna Y; Başar O; Dikici H; Köklü S J Crohns Colitis; 2011 Feb; 5(1):75-6. PubMed ID: 21272812 [No Abstract] [Full Text] [Related]
6. [Possibilities and limits of immunotherapy in multiple sclerosis. Inflammatory and degenerative aspects of the disease require a new pathogenetic concept]. Kornhuber ME; Zierz S Nervenarzt; 2003 Jun; 74(6):537-8; discussion 539. PubMed ID: 12799792 [No Abstract] [Full Text] [Related]
8. The treatment of multiple sclerosis: current and future. Polman CH; Hartung HP Curr Opin Neurol; 1995 Jun; 8(3):200-9. PubMed ID: 7551119 [TBL] [Abstract][Full Text] [Related]
9. Induction and maintenance of clinical remission by interferon-beta in patients with steroid-refractory active ulcerative colitis-an open long-term pilot trial. Musch E; Andus T; Malek M Aliment Pharmacol Ther; 2002 Jul; 16(7):1233-9. PubMed ID: 12144572 [TBL] [Abstract][Full Text] [Related]
10. Interferon-beta1b for the treatment of multiple sclerosis. Lam S; Wang S; Gottesman M Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1111-7. PubMed ID: 18680445 [TBL] [Abstract][Full Text] [Related]
14. Newer versus older treatments for relapsing-remitting multiple sclerosis. Weinstock-Guttman B; Cohen JA Drug Saf; 1996 Feb; 14(2):121-30. PubMed ID: 8852526 [TBL] [Abstract][Full Text] [Related]
15. What is new in the treatment of multiple sclerosis? Weinstock-Guttman B; Jacobs LD Drugs; 2000 Mar; 59(3):401-10. PubMed ID: 10776827 [TBL] [Abstract][Full Text] [Related]
16. Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS. Tremlett HL; Oger J Neurology; 2003 Aug; 61(4):551-4. PubMed ID: 12939437 [TBL] [Abstract][Full Text] [Related]
17. Acute delirium, delusion, and depression during IFN-beta-1a therapy for multiple sclerosis: a case report. Goëb JL; Cailleau A; Lainé P; Etcharry-Bouyx F; Maugin D; Duverger P; Gohier B; Rannou-Dubas K; Dubas F; Garré JB Clin Neuropharmacol; 2003; 26(1):5-7. PubMed ID: 12567157 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis. Dhib-Jalbut S Neurology; 2002 Apr; 58(8 Suppl 4):S3-9. PubMed ID: 11971121 [TBL] [Abstract][Full Text] [Related]
19. Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis. Zang Y; Hong J; Robinson R; Li S; Rivera VM; Zhang JZ J Neuroimmunol; 2003 Apr; 137(1-2):144-53. PubMed ID: 12667659 [TBL] [Abstract][Full Text] [Related]
20. To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes. Frohman EM; Racke M; van Den Noort S Arch Neurol; 2000 Jul; 57(7):930-2. PubMed ID: 10891973 [No Abstract] [Full Text] [Related] [Next] [New Search]